2026 SPS Seattle | Taletrectinib Pushing Progression-Free-Survival (PFS) Boundaries in the ROS1+ Non-Small Cell Lung Cancer Setting (NSCLC)
0% Complete
Course Content
This material is non-CME, no credits are available, and a certificate will not be provided upon completion.
Course Details
- Duration
- 0.00 hour
- Released
- Oct 26, 2026
- Last Review
- Oct 26, 2026
- Expires
- Oct 26, 2029
Target Audience
Pharmacists
Pharmacy Technicians
Accreditation
N/A
